N. Caria - Concepedia

Author

N. Caria

The University of Texas MD Anderson Cancer Center

Also Known As

N Caria, N. Caria, Nicola Caria, Nicola De Caria

Publications

635

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Memorial Sloan Kettering Cancer Center Varian Medical Systems (United States)Università Cattolica del Sacro Cuore

About

N. Caria is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	352
2	Health Sciences	3	3	313
3	Pharmacology	1	1	39
4	Radiation Medicine	1	1	71
5	Adaptive Radiotherapy	1	1	176

N. Caria

Publications

484

Citations

H-Index

Page 1

	Year	Citations
Intensity-Modulated Radiotherapy in the Treatment of Oropharyngeal Cancer: An Update of the Memorial Sloan-Kettering Cancer Center Experience Jeremy Setton, N. Caria, Jonathan Romanyshyn, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyCancer TherapeuticsRadiation TherapyMedicineOropharyngeal Cancer	2010	176
Intensity-Modulated Radiation Therapy in Oropharyngeal Carcinoma: Effect of Tumor Volume on Clinical Outcomes Benjamin H. Lok, Jeremy Setton, N. Caria, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineIntensity-modulated Radiation TherapyRadiation TherapyMedicineClinical Outcomes	2011	71
Target Volume Delineation in Oropharyngeal Cancer: Impact of PET, MRI, and Physical Examination Anuradha Thiagarajan, N. Caria, Heiko Schöder, International Journal of Radiation OncologyBiologyPhysics Medical ImagingMedicinePet-mriTarget Volume DelineationOropharyngeal Cancer	2011	66
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system Maria Antonietta Gambacorta, Chiara Valentini, N. Dinapoli, Acta Oncologica	2013	57
Triplet therapy (continuous ribociclib, everolimus, exemestane) in HR+/HER2− advanced breast cancer postprogression on a CDK4/6 inhibitor (TRINITI-1): Efficacy, safety, and biomarker results. Aditya Bardia, Sara A. Hurvitz, Angela DeMichele, Journal of Clinical Oncology Molecular PharmacologyBreast OncologyOncologyContinuous RibociclibBreast Cancer Postprogression	2019	39
Irradiation of Pacemakers and Cardio-Defibrillators in Patients Submitted to Radiotherapy: A Clinical Experience Teresa Ferrara, Barbara Baiotto, Giuseppe Malinverni, Tumori Journal	2010	37
TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Xiuning Le, Cliff Molife, Mark S. Leusch, Cancers	2022	22
Automatic segmentation software in locally advanced rectal cancer: READY (REsearch program in Auto Delineation sYstem)-RECTAL 02: prospective study Maria Antonietta Gambacorta, Luca Boldrini, Chiara Valentini, Oncotarget	2016	16

Page 1